Align Technology, Inc. (NASDAQ:ALGN) VP Julie Tay sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $253.00, for a total transaction of $885,500.00. Following the sale, the vice president now directly owns 12,213 shares of the company’s stock, valued at approximately $3,089,889. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Align Technology, Inc. (ALGN) traded up $4.27 during trading on Tuesday, hitting $253.73. 952,400 shares of the stock traded hands, compared to its average volume of 1,005,870. The stock has a market cap of $20,430.00, a PE ratio of 73.81, a PEG ratio of 2.39 and a beta of 1.41. Align Technology, Inc. has a 1-year low of $88.56 and a 1-year high of $257.60.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The business had revenue of $385.30 million for the quarter, compared to analysts’ expectations of $359.80 million. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The company’s revenue was up 38.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.63 EPS. equities research analysts expect that Align Technology, Inc. will post 3.62 earnings per share for the current fiscal year.

WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.watchlistnews.com/align-technology-inc-algn-vp-julie-tay-sells-3500-shares/1703331.html.

Several equities research analysts recently issued reports on ALGN shares. Credit Suisse Group AG restated a “positive” rating and issued a $261.00 target price (up previously from $209.00) on shares of Align Technology in a report on Thursday, November 9th. Zacks Investment Research upgraded shares of Align Technology from a “hold” rating to a “buy” rating and set a $227.00 target price on the stock in a report on Monday, October 30th. Stifel Nicolaus raised their target price on shares of Align Technology from $205.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, October 23rd. Robert W. Baird restated a “buy” rating and issued a $245.00 target price on shares of Align Technology in a report on Friday, October 27th. Finally, Leerink Swann restated an “outperform” rating and issued a $250.00 target price on shares of Align Technology in a report on Friday, October 27th. Eleven research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus target price of $219.18.

Institutional investors have recently modified their holdings of the company. Whittier Trust Co. purchased a new position in shares of Align Technology during the 3rd quarter worth $107,000. CENTRAL TRUST Co boosted its stake in shares of Align Technology by 128.5% during the 2nd quarter. CENTRAL TRUST Co now owns 697 shares of the medical equipment provider’s stock worth $105,000 after acquiring an additional 392 shares during the last quarter. Schroder Investment Management Group purchased a new position in shares of Align Technology during the 2nd quarter worth $104,000. Bronfman E.L. Rothschild L.P. boosted its stake in shares of Align Technology by 13.0% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 912 shares of the medical equipment provider’s stock worth $137,000 after acquiring an additional 105 shares during the last quarter. Finally, BlueMountain Capital Management LLC purchased a new position in shares of Align Technology during the 2nd quarter worth $148,000. Institutional investors and hedge funds own 80.86% of the company’s stock.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.